SteadyMed Therapeutics

About:

SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.

Website: http://www.steadymed.com

Twitter/X: SMTherapeutics

Top Investors: OrbiMed, Deerfield, Adage Capital Management, KB Partners, Deerfield Capital Management

Description:

SteadyMed Ltd. is a medical-device company pursuing innovative devices for delivering injectable therapeutic drugs for pain relief, diabetes and other chronic conditions. The company's products are pre-filled drug-infusion patches that will be sold in conjunction with a series of pharma and device companies. Specific applications of the device will be tailored in accordance with the requirements of the company's partners.

Total Funding Amount:

$114M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tel Aviv, Tel Aviv, Israel

Founded Date:

2005-01-01

Founders:

Ian Solomon, Yossi Aldar

Number of Employees:

11-50

Last Funding Date:

2017-05-26

IPO Status:

Public

Industries:

© 2025 bioDAO.ai